zebrafish;
Danio rerio;
bioassay-guided fractionation;
chemical genetics;
in vivo drug discovery;
D O I:
10.1055/s-2008-1034374
中图分类号:
Q94 [植物学];
学科分类号:
071001 ;
摘要:
Emerging challenges within the current drug discovery paradigm are prompting renewed interest in natural products as a source of novel, bioactive small molecules. With the recent validation of zebrafish as a biomedically relevant model for functional genomics and in vivo drug discovery, the zebrafish bioassay-guided identification of natural products may be an attractive strategy to generate new lead compounds in a number of indication areas. Here, we review recent natural product research using zebrafish and evaluate the potential of this vertebrate model as a discovery platform for the systematic identification of bioactive natural products.
机构:
Univ Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USA
机构:
Univ Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USA